RecruitingPhase 2NCT05538208
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Studying Pediatric systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Principal Investigator
- Hermine I Brunner, MD, MDChildren's Hospital Medical Center, Cincinnati
- Intervention
- Mycophenolate Mofetil(drug)
- Enrollment
- 105 target
- Eligibility
- 8-20 years · All sexes
- Timeline
- 2024 – 2027
Study locations (19)
- University of California, San Francisco, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Emory Children's Center, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Chicago Medicine- Comer Children's, Chicago, Illinois, United States
- Washington University in St. Louis School of Medicine, St Louis, Missouri, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Hospital for Special Surgery, New York, New York, United States
- Children's Hospital at Montefiore, New York, New York, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Akron Children's Hospital, Akron, Ohio, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- +4 more locations on ClinicalTrials.gov
Collaborators
Genentech, Inc. · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05538208 on ClinicalTrials.govOther trials for Pediatric systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07425730Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric LupusShanghai Jiao Tong University School of Medicine
- RECRUITINGNCT07128966Direct to Patient Minimal Risk Biospecimen and Data Collection ResearchJoined Bio
- RECRUITINGPHASE3NCT05835310An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsAstraZeneca
- RECRUITINGNANCT06586710Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLEMeyer Children's Hospital IRCCS
- RECRUITINGPHASE2NCT05039619A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsHoffmann-La Roche
- ACTIVE NOT RECRUITINGPHASE2NCT04179032Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)GlaxoSmithKline